1. Home
  2. IHT vs LNAI Comparison

IHT vs LNAI Comparison

Compare IHT & LNAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InnSuites Hospitality Trust Shares of Beneficial Interest

IHT

InnSuites Hospitality Trust Shares of Beneficial Interest

HOLD

Current Price

$1.45

Market Cap

13.3M

Sector

Finance

ML Signal

HOLD

Logo Lunai Bioworks Inc.

LNAI

Lunai Bioworks Inc.

HOLD

Current Price

$2.30

Market Cap

11.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IHT
LNAI
Founded
1971
N/A
Country
United States
United States
Employees
N/A
29
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.3M
11.7M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
IHT
LNAI
Price
$1.45
$2.30
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
11.8K
430.2K
Earning Date
05-12-2026
05-14-2026
Dividend Yield
1.77%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,600,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1.33
N/A
52 Week Low
$0.95
$0.15
52 Week High
$4.24
$3.38

Technical Indicators

Market Signals
Indicator
IHT
LNAI
Relative Strength Index (RSI) 58.78 64.19
Support Level $1.37 $0.93
Resistance Level $1.51 $3.38
Average True Range (ATR) 0.08 0.28
MACD -0.01 0.01
Stochastic Oscillator 44.00 66.15

Price Performance

Historical Comparison
IHT
LNAI

About IHT InnSuites Hospitality Trust Shares of Beneficial Interest

InnSuites Hospitality Trust is a real estate investment trust. It is engaged in the ownership and operation of hotel properties. It owns and operates hotels, provides management services for hotels, and also provides trademark license services. The Trust is also involved in various operations incidental to the operation of hotels, such as the operation of restaurants, meeting/banquet room rentals, and the operation of a reservation system. It has one reportable segment Hotel Operations & Hotel Management Services.

About LNAI Lunai Bioworks Inc.

Lunai Bioworks Inc is a biopharmaceutical company. Through its subsidiaries, it is mainly focused on developing allogeneic cell and gene therapies to promote stronger immune system responses, potentially for long-term or life-long cancer remission in some of the deadliest cancers. The group is engaged in the development of RENB-DC11 and RENB-DC20 (potential cell therapeutic vaccine candidates for different types of cancer); a proprietary AI platform that analyzes genetics to provide earlier and more accurate cancer diagnosis; and machine learning pipelines that harmonize and analyze complex, heterogeneous datasets to uncover clinically actionable insights. The group's reportable segments are: RENB, BioSymetrics, and RENC. Geographically, it operates in the United States and Netherlands.

Share on Social Networks: